Genetics

US tells 23andMe to halt sales of genetic test

The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.

Medications

Guidelines agree on opioid risk mitigation strategies

(HealthDay)—Recent guidelines on chronic pain management agree on several opioid risk mitigation strategies, according to a review published online Nov. 12 in the Annals of Internal Medicine.

Diseases, Conditions, Syndromes

Potential new treatment for colitis

A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta.

Addiction

Innovative testing program detects emerging drugs

Emerging drugs of abuse in communities can be rapidly identified by an innovative urine testing system, according to the results of a recently released pilot study conducted by the Center for Substance Abuse Research (CESAR) ...

Addiction

Racial differences exist in reports of workplace drug testing

(Medical Xpress)—Drug testing occurs more often in workplaces where racial and ethnic minorities are employed, according to a new study by Yale School of Medicine. The study appears online in the Early View of the American ...

page 40 from 40